Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension

Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension

Bibliographic Details
Main Authors: Baumgart, Peter, Naudts, Ingomar, Kiel, Gerhard
Format: Online
Language:English
Published: Dove Medical Press 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045001/
id pubmed-5045001
recordtype oai_dc
spelling pubmed-50450012016-10-21 Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension Baumgart, Peter Naudts, Ingomar Kiel, Gerhard Original Research Dove Medical Press 2011-04-29 /pmc/articles/PMC5045001/ /pubmed/27774009 http://dx.doi.org/10.2147/POR.S18303 Text en © 2011 Baumgart et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Baumgart, Peter
Naudts, Ingomar
Kiel, Gerhard
spellingShingle Baumgart, Peter
Naudts, Ingomar
Kiel, Gerhard
Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
author_facet Baumgart, Peter
Naudts, Ingomar
Kiel, Gerhard
author_sort Baumgart, Peter
title Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
title_short Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
title_full Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
title_fullStr Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
title_full_unstemmed Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
title_sort introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
description
publisher Dove Medical Press
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045001/
_version_ 1613668303586197504

Similar Items